CC

Commodore Capital Portfolio holdings

AUM $2.05B
1-Year Est. Return 118.14%
This Quarter Est. Return
1 Year Est. Return
+118.14%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.42B
AUM Growth
+$59.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$59.4M
2
+$57.2M
3
+$46.2M
4
KYMR icon
Kymera Therapeutics
KYMR
+$32.7M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$21.9M

Top Sells

1
+$62.3M
2
+$49.9M
3
+$47.3M
4
SLNO icon
Soleno Therapeutics
SLNO
+$45.2M
5
VERA icon
Vera Therapeutics
VERA
+$41.5M

Sector Composition

1 Healthcare 99.44%
2 Financials 0.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRUS
1
DELISTED
Merus
MRUS
$185M 13.09%
3,525,000
-947,840
NUVL icon
2
Nuvalent
NUVL
$8.22B
$105M 7.41%
1,375,000
-480,000
XENE icon
3
Xenon Pharmaceuticals
XENE
$3.27B
$94.7M 6.68%
3,025,000
+700,000
ELVN icon
4
Enliven Therapeutics
ELVN
$1.54B
$94.1M 6.64%
4,692,809
+17,809
AGIO icon
5
Agios Pharmaceuticals
AGIO
$1.68B
$77.3M 5.46%
2,325,000
+140,000
CLDX icon
6
Celldex Therapeutics
CLDX
$1.76B
$70.2M 4.96%
3,450,000
+250,000
ALKS icon
7
Alkermes
ALKS
$5.46B
$70.1M 4.95%
2,450,000
+500,000
VRDN icon
8
Viridian Therapeutics
VRDN
$3.15B
$68.2M 4.81%
4,875,000
+1,275,000
PTGX icon
9
Protagonist Therapeutics
PTGX
$5.15B
$59.4M 4.19%
+1,075,000
CDTX
10
DELISTED
Cidara Therapeutics
CDTX
$57.2M 4.04%
+1,175,000
SRRK icon
11
Scholar Rock
SRRK
$4.56B
$51.4M 3.63%
1,450,000
-295,000
SLNO icon
12
Soleno Therapeutics
SLNO
$2.3B
$51.1M 3.61%
610,000
-540,000
RLAY icon
13
Relay Therapeutics
RLAY
$1.29B
$46.2M 3.26%
+13,350,000
NRIX icon
14
Nurix Therapeutics
NRIX
$1.9B
$45M 3.17%
3,948,653
-30,254
CNTA
15
Centessa Pharmaceuticals
CNTA
$3.78B
$43.3M 3.06%
3,298,289
+930,711
PHVS icon
16
Pharvaris
PHVS
$1.78B
$33.6M 2.37%
1,911,433
KYMR icon
17
Kymera Therapeutics
KYMR
$5.64B
$32.7M 2.31%
+750,000
DFTX
18
Definium Therapeutics
DFTX
$1.65B
$32.5M 2.29%
5,000,000
+475,000
SYRE icon
19
Spyre Therapeutics
SYRE
$2.51B
$29.8M 2.1%
1,988,084
TYRA icon
20
Tyra Biosciences
TYRA
$1.6B
$29.7M 2.09%
3,100,000
+2,150,000
VERA icon
21
Vera Therapeutics
VERA
$3.32B
$18.8M 1.33%
800,000
-1,761,782
CTMX icon
22
CytomX Therapeutics
CTMX
$903M
$17.5M 1.23%
+7,692,300
COGT icon
23
Cogent Biosciences
COGT
$5.8B
$16.6M 1.17%
2,311,164
-6,581,652
ORKA
24
Oruka Therapeutics
ORKA
$1.66B
$15.9M 1.12%
1,419,714
DRUG
25
Bright Minds Biosciences
DRUG
$837M
$13.1M 0.92%
500,000
1
2